| scholarly article | Q13442814 |
| P2093 | author name string | Thomas McCown | |
| Zhen Ming | |||
| George Breese | |||
| Rebecca Haberman | |||
| Hugh Criswell | |||
| R Samulski | |||
| Stephen Snowdy | |||
| P2860 | cites work | Heteromeric NMDA receptors: molecular and functional distinction of subtypes | Q28182183 |
| PIN: an associated protein inhibitor of neuronal nitric oxide synthase | Q28293334 | ||
| Cloned glutamate receptors | Q29619950 | ||
| Tufted cell dendrodendritic inhibition in the olfactory bulb is dependent on NMDA receptor activity | Q31816863 | ||
| Selective and rapid uptake of adeno-associated virus type 2 in brain | Q34471578 | ||
| Reduced MK801 binding in neocortical neurons after AAV-mediated transfections with NMDA-R1 antisense cDNA. | Q38338178 | ||
| Effects of NMDA-R1 antisense oligodeoxynucleotide administration: behavioral and radioligand binding studies. | Q38349251 | ||
| Novel transcriptional regulatory signals in the adeno-associated virus terminal repeat A/D junction element | Q39612405 | ||
| Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease | Q40861090 | ||
| Glutamate, GABA and epilepsy | Q41095763 | ||
| Modulation of calcium channels by norepinephrine in internally dialyzed avian sensory neurons | Q41981192 | ||
| Amino acid influences on seizures elicited within the inferior colliculus | Q42202246 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| NGF gene transfer to intrinsic basal forebrain neurons increases cholinergic cell size and protects from age-related, spatial memory deficits in middle-aged rats | Q42492745 | ||
| Neuroanatomical characterization of inferior collicular seizure genesis: 2-deoxyglucose and stimulation mapping | Q44407776 | ||
| Inducible long-term gene expression in brain with adeno-associated virus gene transfer | Q45751214 | ||
| Adeno-associated virus (AAV) vector antisense gene transfer in vivo decreases GABA(A) alpha1 containing receptors and increases inferior collicular seizure sensitivity | Q45762593 | ||
| Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters | Q45764253 | ||
| Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector | Q45769447 | ||
| Prolonged reduction of high blood pressure with an in vivo, nonpathogenic, adeno-associated viral vector delivery of AT1-R mRNA antisense | Q45880717 | ||
| Electrically elicited seizures from the inferior colliculus: a potential site for the genesis of epilepsy? | Q48596133 | ||
| Chronic ethanol increases N-methyl-D-aspartate-stimulated nitric oxide formation but not receptor density in cultured cortical neurons | Q48720715 | ||
| Anticonvulsant effect of reduced NMDA receptor expression in audiogenic DBA/2 mice | Q48847035 | ||
| Sources of GABAergic input to the inferior colliculus of the rat. | Q48941451 | ||
| Induction of audiogenic seizures in normal and genetically epilepsy-prone rats following focal microinjection of an excitant amino acid into reticular formation and auditory nuclei | Q69506357 | ||
| Sticky-end PCR: new method for subcloning | Q77136560 | ||
| P433 | issue | 4 | |
| P921 | main subject | vector-borne disease | Q2083837 |
| seizure | Q6279182 | ||
| P304 | page(s) | 495-500 | |
| P577 | publication date | 2002-10-01 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | Therapeutic liabilities of in vivo viral vector tropism: adeno-associated virus vectors, NMDAR1 antisense, and focal seizure sensitivity | |
| P478 | volume | 6 |
| Q92155680 | A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy |
| Q38075068 | A next step in adeno-associated virus-mediated gene therapy for neurological diseases: regulation and targeting. |
| Q99559722 | AAV Capsid-Promoter Interactions in the Brain Translate from Rat to the Non-Human Primate |
| Q61976265 | AAV for disorders of the CNS |
| Q37140645 | AAV vectors for RNA-based modulation of gene expression |
| Q38856794 | Adeno-Associated Virus-Based Gene Therapy for CNS Diseases. |
| Q37426979 | Adeno-associated virus vector-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity |
| Q34531327 | Adeno-associated virus-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity in vivo |
| Q34788009 | Adenosine kinase as a target for therapeutic antisense strategies in epilepsy |
| Q30605561 | Adenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsy |
| Q34542364 | An adeno-associated virus-based intracellular sensor of pathological nuclear factor-κB activation for disease-inducible gene transfer |
| Q44511379 | Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion |
| Q40404005 | Audiogenic seizure activity following HSV-1 GAD65 sense or antisense injection into inferior colliculus of Long-Evans rat. |
| Q28081164 | Changing channels in pain and epilepsy: Exploiting ion channel gene therapy for disorders of neuronal hyperexcitability |
| Q27002627 | Current prospects and challenges for epilepsy gene therapy |
| Q33685490 | Engineered HSV vector achieves safe long-term transgene expression in the central nervous system |
| Q36840599 | Etiology and management of refractory epilepsies |
| Q34375803 | Gene therapy for epilepsy. |
| Q33960096 | Gene therapy in epilepsy |
| Q34410588 | Gene therapy in epilepsy-is it time for clinical trials? |
| Q34126428 | Inhibitory RNA in epilepsy: research tools and therapeutic perspectives |
| Q30451702 | Knockdown and overexpression of NR1 modulates NMDA receptor function. |
| Q95642591 | Lentiviral vector-mediated transduction of adult neural stem/progenitor cells isolated from the temporal tissues of epileptic patients |
| Q37426975 | Neuropeptide Y overexpression using recombinant adeno-associated viral vectors. |
| Q42008294 | On demand up-regulation of therapeutic genes in the brain: fiction or reality? |
| Q41841802 | Preferential labeling of inhibitory and excitatory cortical neurons by endogenous tropism of adeno-associated virus and lentivirus vectors. |
| Q38100997 | Progress in gene therapy for neurological disorders. |
| Q40596482 | RANGE: Gene Transfer of Reversibly Controlled Polycistronic Genes |
| Q34098055 | Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy |
| Q36368045 | Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders. |
| Q73741319 | Seizing hold of seizures |
| Q37021317 | The promise of gene therapy for the treatment of epilepsy |
| Q35120134 | Viral vectors for gene delivery to the nervous system |
Search more.